| 36.08 Real-Time Quote |  -0.24 / -0.66%Today’s Change | 3.30 Today|||52-Week Range 45.00 | +39.84% Year-to-Date |
| Requiem for the Bears May 17 / TheStreet.com | Sarepta Therapeutics Inc (SRPT): Today's Featured Drugs Winner May 16 / TheStreet.com |
| Digging for New Buys May 17 / TheStreet.com |
| Previous close | 36.32 |
| Today’s open | 35.50 |
| Day’s range | 35.23 - 35.57 |
| Volume | 65,239 |
| Average volume (3 months) | 1,981,753 |
| Market cap | $1.2B |
| Dividend yield | -- |
| Earnings growth (last year) | -4,183.33% |
| Earnings growth (this year) | +31.20% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | -20.56% |
| P/E ratio | NM |
| Price/Sales | 16.31 |
| Price/Book | 9.31 |
| Today’s change | Today’s % change | |
|---|---|---|
| PDLIPDL BioPharma Inc | -0.05 | -0.61% |
| INFIInfinity Pharmaceuti... | -0.43 | -1.86% |
| ACADACADIA Pharmaceutica... | -0.34 | -2.53% |
| TSROTESARO Inc | +0.20 | +0.58% |
| Next reporting date | August 12, 2013 |
| EPS forecast (this quarter) | -$0.63 |
| Annual revenue (last year) | $37.3M |
| Annual profit (last year) | -$121.3M |
| Net profit margin | -324.91% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Christopher Nishan Garabedian |
Chief Financial Officer & Senior Vice President Sandesh Mahatme |
Corporate headquarters Bothell, Washington |
.
